Coating of carboxymethyl dextran on liposomal curcumin to improve the anticancer activity

Qiyu Huang, Lili Zhang, Xiaoyi Sun, Ke Zeng, Juan Li*, You Nian Liu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

In this work, carboxymethyl dextran (CMD), a polysaccharidic dextran derivative with well-known biocompatibility and biodegradability, was used to modify curcumin-loaded liposomes for improving the anticancer efficacy of curcumin. The CMDylated curcumin-loaded liposomes (CMD-Cur-Lip) were successfully prepared and characterized in comparison with unmodified and two PEGylated curcumin-loaded liposomes. The results showed that: (1) the encapsulation efficiency of curcumin in the liposomes was improved after being modified with CMD; (2) all the curcumin-loaded liposomes displayed controlled release characteristics; (3) the CMD-Cur-Lip demonstrated improved cell cytotoxicity against cancer cells, as compared to other liposomal formulations and free curcumin; (4) CMD-Cur-Lip exhibited the highest cellular uptake as compared to other liposomal formulations.

Original languageEnglish
Pages (from-to)59211-59217
Number of pages7
JournalRSC Advances
Volume4
Issue number103
DOIs
Publication statusPublished - 28 Oct 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Coating of carboxymethyl dextran on liposomal curcumin to improve the anticancer activity'. Together they form a unique fingerprint.

Cite this